Class Action Over Cephalon Off-Label Claims Tossed

Law360 (October 9, 2009, 2:08 PM EDT) -- Cephalon Inc. has won dismissal of a putative class action brought by a group of municipal benefit funds over the pharmaceutical company's alleged efforts to market three drugs for uses that did not have regulatory approval.

Judge Mary L. Cooper of the U.S. District Court for the District of New Jersey dismissed the complaint Wednesday after concluding that the plaintiffs had failed to allege the facts needed to support their claims. Part of the case was dismissed without prejudice.

The suit claims Central Regional Employees Benefit Fund and other benefit funds have lost "tens of millions of dollars" because they provided...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!